News Biden plan would axe interchangeable status for biosimilars President Joe Biden’s budget proposal for fiscal 2025 includes a proposal that would allow pharmacy substitution of biosimilar drugs for the reference product, even if the
News Samsung seeks 'interchangeable' label for Humira biosimilar While there are already a number of biosimilars of AbbVie's big-selling Humira on the US market, so far, only one – Boehringer Ingelheim's
Partner Content Partner Content Four Key Reasons to Attend SMi's 2019 Biosimilars Conference Four Key Reasons to Attend SMi's 2019 Biosimilars
Partner Content Partner Content Michel Mikhail invites Biosimilar experts to attend SMi’s 10... Michel Mikhail invites Biosimilar experts to attend SMi
Partner Content Partner Content Save the date for SMi’s 10th Annual Biosimilars Conference 2... Save the date for SMi’s 10th Annual Biosimilars Conf
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends